CLBT
Cellebrite DI Ltd.
Software - Infrastructure
Market Cap$3.38B
5Y Perf.+38.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CLBT vs OSPN
Revenue, margins, valuation, and 5-year total return — side by side.
OSPN
OneSpan Inc.
Software - Infrastructure
Market Cap$455M
5Y Perf.-38.6%
CLBT vs OSPN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CLBT | OSPN |
|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $3.38B | $455M |
| Revenue (TTM) | $476M | $246M |
| Net Income (TTM) | $78M | $70M |
| Gross Margin | 84.2% | 70.5% |
| Operating Margin | 14.0% | 19.4% |
| Forward P/E | 37.5x | 9.9x |
| Total Debt | $23M | $6M |
| Cash & Equiv. | $124M | $70M |
CLBT vs OSPN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CLBT
OSPN
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Cellebrite DI Ltd. (CLBT) | 100 | 138.7 | +38.7% |
| OneSpan Inc. (OSPN) | 100 | 61.4 | -38.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLBT vs OSPN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: OSPN leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Cellebrite DI Ltd. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CLBT
Cellebrite DI Ltd.
The Income Pick
CLBT is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.76
- Rev growth 18.6%, EPS growth 123.0%, 3Y rev CAGR 20.7%
- 43.0% 10Y total return vs OSPN's -21.7%
Best for: income & stability and growth exposure
OSPN
OneSpan Inc.
The Value Play
OSPN carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (9.9x vs 37.5x)
- 28.5% margin vs CLBT's 16.5%
- 3.9% yield; 2-year raise streak; the other pay no meaningful dividend
Best for: value and quality
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CLBT | 18.6% revenue growth vs OSPN's 0.0% |
| Value | OSPN | Lower P/E (9.9x vs 37.5x) |
| Quality / Margins | OSPN | 28.5% margin vs CLBT's 16.5% |
| Stability / Safety | CLBT | Beta 0.76 vs OSPN's 1.23 |
| Dividends | OSPN | 3.9% yield; 2-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | OSPN | -19.1% vs CLBT's -27.6% |
| Efficiency (ROA) | OSPN | 18.9% ROA vs CLBT's 8.3%, ROIC 21.7% vs 18.5% |
CLBT vs OSPN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
CLBT vs OSPN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCLBTLAGGINGOSPN
OSPNOneSpan Inc.
3leads
CLBTCellebrite DI Ltd.
3leads
6 Total Categories
CATEGORYLEADERvs OSPNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CLBT4/6
Valuation MetricsMultiples, price ratios, and targets
OSPN6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
OSPN7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
CLBT4/6
Risk & VolatilityBeta, volatility, and downside exposure
CLBT2/2
Analyst OutlookRatings, price targets, and dividends
OSPN1/1
Income & Cash Flow (Last 12 Months)
CLBT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLBT is the larger business by revenue, generating $476M annually — 1.9x OSPN's $246M. OSPN is the more profitable business, keeping 28.5% of every revenue dollar as net income compared to CLBT's 16.5%. On growth, CLBT holds the edge at +18.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| RevenueTrailing 12 months | $476M | $246M |
| EBITDAEarnings before interest/tax | $78M | $57M |
| Net IncomeAfter-tax profit | $78M | $70M |
| Free Cash FlowCash after capex | $160M | $47M |
| Gross MarginGross profit ÷ Revenue | +84.2% | +70.5% |
| Operating MarginEBIT ÷ Revenue | +14.0% | +19.4% |
| Net MarginNet income ÷ Revenue | +16.5% | +28.5% |
| FCF MarginFCF ÷ Revenue | +33.7% | +19.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.1% | +4.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | -18.9% |
CLBT leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
OSPN leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, OSPN trades at a 86% valuation discount to CLBT's 44.5x P/E. On an enterprise value basis, OSPN's 6.0x EV/EBITDA is more attractive than CLBT's 41.8x.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| Market CapShares × price | $3.4B | $455M |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $391M |
| Trailing P/EPrice ÷ TTM EPS | 44.55x | 6.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.53x | 9.89x |
| PEG RatioP/E ÷ EPS growth rate | 0.76x | — |
| EV / EBITDAEnterprise value multiple | 41.79x | 6.00x |
| Price / SalesMarket cap ÷ Revenue | 7.10x | 1.87x |
| Price / BookPrice ÷ Book value/share | 7.13x | 1.72x |
| Price / FCFMarket cap ÷ FCF | 21.06x | 9.02x |
OSPN leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
OSPN leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
OSPN delivers a 27.3% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $16 for CLBT. OSPN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CLBT's 0.05x. On the Piotroski fundamental quality scale (0–9), OSPN scores 5/9 vs CLBT's 4/9, reflecting solid financial health.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +16.2% | +27.3% |
| ROA (TTM)Return on assets | +8.3% | +18.9% |
| ROICReturn on invested capital | +18.5% | +21.7% |
| ROCEReturn on capital employed | +13.8% | +19.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.05x | 0.02x |
| Net DebtTotal debt minus cash | -$102M | -$64M |
| Cash & Equiv.Liquid assets | $124M | $70M |
| Total DebtShort + long-term debt | $23M | $6M |
| Interest CoverageEBIT ÷ Interest expense | — | 1656.95x |
OSPN leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
CLBT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CLBT five years ago would be worth $13,992 today (with dividends reinvested), compared to $4,969 for OSPN. Over the past 12 months, OSPN leads with a -19.1% total return vs CLBT's -27.6%. The 3-year compound annual growth rate (CAGR) favors CLBT at 36.3% vs OSPN's -2.4% — a key indicator of consistent wealth creation.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -22.6% | -0.1% |
| 1-Year ReturnPast 12 months | -27.6% | -19.1% |
| 3-Year ReturnCumulative with dividends | +153.4% | -7.0% |
| 5-Year ReturnCumulative with dividends | +39.9% | -50.3% |
| 10-Year ReturnCumulative with dividends | +43.0% | -21.7% |
| CAGR (3Y)Annualised 3-year return | +36.3% | -2.4% |
CLBT leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
CLBT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CLBT is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than OSPN's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.23x |
| 52-Week HighHighest price in past year | $20.45 | $18.13 |
| 52-Week LowLowest price in past year | $11.02 | $10.07 |
| % of 52W HighCurrent price vs 52-week peak | +67.5% | +67.0% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 61.5 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 599K |
CLBT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
OSPN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CLBT as "Buy" and OSPN as "Buy". Consensus price targets imply 49.7% upside for CLBT (target: $21) vs 27.6% for OSPN (target: $16). OSPN is the only dividend payer here at 3.95% yield — a key consideration for income-focused portfolios.
| Metric | CLBTCellebrite DI Ltd. | OSPNOneSpan Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $20.67 | $15.50 |
| # AnalystsCovering analysts | 8 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +3.9% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $0.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.9% |
OSPN leads this category, winning 1 of 1 comparable metric.
Key Takeaway
CLBT leads in 3 of 6 categories (Income & Cash Flow, Total Returns). OSPN leads in 3 (Valuation Metrics, Profitability & Efficiency).
Best OverallCellebrite DI Ltd. (CLBT)Leads 3 of 6 categories
Loading custom metrics...
CLBT vs OSPN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CLBT or OSPN a better buy right now?
For growth investors, Cellebrite DI Ltd.
(CLBT) is the stronger pick with 18. 6% revenue growth year-over-year, versus 0. 0% for OneSpan Inc. (OSPN). OneSpan Inc. (OSPN) offers the better valuation at 6. 4x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate Cellebrite DI Ltd. (CLBT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLBT or OSPN?
On trailing P/E, OneSpan Inc.
(OSPN) is the cheapest at 6. 4x versus Cellebrite DI Ltd. at 44. 5x. On forward P/E, OneSpan Inc. is actually cheaper at 9. 9x.
03Which is the better long-term investment — CLBT or OSPN?
Over the past 5 years, Cellebrite DI Ltd.
(CLBT) delivered a total return of +39. 9%, compared to -50. 3% for OneSpan Inc. (OSPN). Over 10 years, the gap is even starker: CLBT returned +43. 0% versus OSPN's -21. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLBT or OSPN?
By beta (market sensitivity over 5 years), Cellebrite DI Ltd.
(CLBT) is the lower-risk stock at 0. 76β versus OneSpan Inc. 's 1. 23β — meaning OSPN is approximately 62% more volatile than CLBT relative to the S&P 500. On balance sheet safety, OneSpan Inc. (OSPN) carries a lower debt/equity ratio of 2% versus 5% for Cellebrite DI Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLBT or OSPN?
By revenue growth (latest reported year), Cellebrite DI Ltd.
(CLBT) is pulling ahead at 18. 6% versus 0. 0% for OneSpan Inc. (OSPN). On earnings-per-share growth, the picture is similar: Cellebrite DI Ltd. grew EPS 123. 0% year-over-year, compared to 30. 1% for OneSpan Inc.. Over a 3-year CAGR, CLBT leads at 20. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLBT or OSPN?
OneSpan Inc.
(OSPN) is the more profitable company, earning 30. 0% net margin versus 16. 5% for Cellebrite DI Ltd. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSPN leads at 20. 6% versus 14. 0% for CLBT. At the gross margin level — before operating expenses — CLBT leads at 84. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLBT or OSPN more undervalued right now?
On forward earnings alone, OneSpan Inc.
(OSPN) trades at 9. 9x forward P/E versus 37. 5x for Cellebrite DI Ltd. — 27. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLBT: 49. 7% to $20. 67.
08Which pays a better dividend — CLBT or OSPN?
In this comparison, OSPN (3.
9% yield) pays a dividend. CLBT does not pay a meaningful dividend and should not be held primarily for income.
09Is CLBT or OSPN better for a retirement portfolio?
For long-horizon retirement investors, OneSpan Inc.
(OSPN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 3. 9% yield). Both have compounded well over 10 years (OSPN: -21. 7%, CLBT: +43. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLBT and OSPN?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CLBT is a small-cap high-growth stock; OSPN is a small-cap deep-value stock. OSPN pays a dividend while CLBT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CLBT: 18.1% · OSPN: 4.1%)Net Margin>
%
(CLBT: 16.5% · OSPN: 28.5%)P/E Ratio<
x
(CLBT: 44.5x · OSPN: 6.4x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.